TC BioPharm (Holdings)の空売り状況は、投資家がTC BioPharm (Holdings)の株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

TC BioPharm (Holdings) (OTC:TCBPY) 株価情報, 空売り情報

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.

TC BIOPHARM HLDGS SP/ADR by TC BioPharm (Holdings) plc

TC BioPharm (Holdings) PLC

<a href="https://www.benzinga.com/topic/warren-buffett">Warren Buffett</a> and <a href="https://www.benzinga.com/topic/cathie-woodhttps://www.benzinga.com/topic/cathie-wood">Cathie Wood</a> may both be stock-picking legends, but their portfolios might as well be from different galaxies. While Buffett cruises the investing seas with old-school juggernauts, Wood launches rockets hoping they'll land on the moon &#8211; or at least avoid burning up on re-entry.
<h2 class="wp-block-heading">Tech Vs. Tact: A Tale Of Two Strategies</h2>
Data from HedgeFollow <a href="https://hedgefollow.com/funds/Berkshire+Hathaway" target="_blank" rel="noopener">suggests that</a> in the fourth quarter of 2024, Buffett's Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) clocked in a respectable 2.74% gain, quietly pushing his war chest to a towering $267 billion.
Meanwhile, Cathie Wood's ARK Innovation Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#BATS">ARKK</a>) lit up with a scorching 23.82% quarterly return &#8211; but before ARK fans pop champagne, the long-term picture tells a more sobering story.
Over the past three years, Buffett's top 50 holdings (weighted) returned +20.29%, while Wood's delivered a bruising -33.63%. That's not just a bad quarter &#8211; it's a full-blown crash landing.
<h2 class="wp-block-heading">Buffett's Billion-Dollar Boring Works Brilliantly</h2>
The difference? 
Buffett's portfolio is a fortress of slow-burning compounders. His crown jewel, Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), takes up 28% of his portfolio and has returned a jaw-dropping +438.8% from its average buy price.
Throw in American Express Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) (+277.6%), Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) (+55.8%) and Coca-Cola Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) (+77%), and it's clear the Oracle of Omaha is still the king of buying great companies at great prices… and holding them forever.
Read Also: <a href="https://www.benzinga.com/25/04/44969765/cathie-wood-buys-more-nvidia-and-amd-stock-as-chinese-tech-giants-stockpile-chips-amid-looming-us-export-curbs">Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs</a>
<h2 class="wp-block-heading">Cathie's High-Flyers Keep Crashing Back To Earth</h2>
Cathie Wood, on the other hand, is all about "disruption" — and sometimes, the disruption is in her portfolio&#8217;s value. Take Roku Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>), down 46.6% from her average buy-in, and Block Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>), down -50.1%. Her top bets, like Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Coinbase Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), have had moments of glory, but the overall portfolio has been whipsawed by volatility and drawn-out tech drawdowns.
To her credit, Wood&#8217;s fourth-quarter comeback shows that high-beta bets can pay off—just not consistently. While her fund has a whopping 181 holdings, many are moonshots still waiting for liftoff.
Overall, Buffett's performance shows the power of patience and pricing. Wood? She's still betting on the future &#8211; but it seems Buffett is quietly owning it.
Which camp would you rather retire in &#8211; the steady compounder or the volatile visionary?
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/25/04/45029505/warren-buffett-reveals-the-one-easy-way-to-become-worth-50-more-than-you-are-now">Warren Buffett Reveals &#8216;The One Easy Way To Become Worth 50% More Than You Are Now&#8217;</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Specialty ETFs

Hedge Funds

Trading Ideas

ETFs

AAPL

ARKK

COIN

ROKU

TSLA

Warren Buffett's Compounders Crush Cathie Wood's Disruptors Over The Long Haul

HC Wainwright &amp; Co. analyst Yi Chen maintains Bausch &amp; Lomb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>) with a Buy and lowers the price target from $20 to $15.

News

Price Target

Analyst Ratings

BLCO

HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Lowers Price Target to $15

Stifel analyst Stephen Gengaro maintains Civeo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVEO#NYSE">CVEO</a>) with a Buy and lowers the price target from $28 to $27.

CVEO

Stifel Maintains Buy on Civeo, Lowers Price Target to $27

Draganfly Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPRO#NASDAQ">DPRO</a>) (CSE:<a class="ticker" href="https://www.benzinga.com/stock/DPRO#CSE">DPRO</a>) (FSE: 3U8A) ("Draganfly" or the "Company"), a drone solutions, and systems developer, today announced the pricing of its previously announced underwritten public offering (the "Offering") of 1,715,000 units, with each unit consisting of one common share and one warrant to purchase one common share. Each unit is to be sold at a public offering price of US$2.10, for gross proceeds of approximately US$3.6 million, before deducting underwriting discounts and offering expenses. The warrants will have an exercise price of CA$3.9779 (or US$2.875) per share, are exercisable immediately and will expire five years following the date of issuance. In addition, the Company granted the underwriter a 45-day over-allotment option to purchase up to an additional 15 percent of the number of common shares and/or warrants offered in the Offering.

Offerings

CSE:DPRO

DPRO

Draganfly Announces Pricing Of US$3.6M Underwritten Public Offering Of 1.71M Units At $2.10 Per Unit

PLPC

Preformed Line Products Acquires JAP Telecom; Terms Not Disclosed

Needham analyst Laura Martin maintains Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) with a Buy and raises the price target from $135 to $145.

RDDT

Needham Maintains Buy on Reddit, Raises Price Target to $145

Stifel analyst Stephen Gengaro maintains Cactus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHD#NYSE">WHD</a>) with a Buy and lowers the price target from $61 to $57.

Stifel Maintains Buy on Cactus, Lowers Price Target to $57

Stifel analyst David Grossman maintains American Well (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMWL#NYSE">AMWL</a>) with a Hold and lowers the price target from $10 to $8.

AMWL

Stifel Maintains Hold on American Well, Lowers Price Target to $8

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XFOR#NASDAQ">XFOR</a>) with a Buy and raises the price target from $1.5 to $7.

XFOR

HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $7

Vagal Neuromodulation Offers a Novel Approach to Treating Diabetes and Hypoglycemia
Device Demonstrates the Ability to Modulate Glucose Levels Without Cardiac Side Effects, Overcoming a Key Limitation Of Conventional Vagal Stimulation Techniques
IRVINE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences&#xAE; (NASDAQ:<a href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>), the premier physician-led weight loss and metabolic health solutions company, today announced it will present pre-clinical data on its proprietary Diabetes Neuromodulation device in a poster presentation at the 12th Annual Minnesota Neuromodulation Symposium, being held in Minneapolis.

RSLS

ReShape Lifesciences To Present Pre-Clinical Data On Proprietary Diabetes Neuromodulation Device At 12Th Annual Minnesota Neuromodulation Symposium

Stifel analyst Mark Kelley maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Buy and lowers the price target from $248 to $245.

AMZN

Stifel Maintains Buy on Amazon.com, Lowers Price Target to $245

<ul>
<li>Company Aims to Exceed 1,000 Advertisers by Mid-Q2 and 5,000 Advertisers by the End of 2025</li>
<li>Thumzup's Plans Further Accelerate Growth and Market Penetration of its Innovative AdTech Platform</li>
</ul>
LOS ANGELES, May 2, 2025 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4418767-1&amp;h=2562076278&amp;u=https%3A%2F%2Fwww.thumzupmedia.com%2F&amp;a=Thumzup+Media+Corporation">Thumzup Media Corporation</a> ("Thumzup" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZUP#NASDAQ">TZUP</a>), an emerging leader in social media branding and programmatic marketing solutions, is excited to announce it has surpassed 900 advertisers, a CAGR (Compound Annual Growth Rate) of 220%, marking a significant milestone in the Company's rapid expansion within the digital advertising space. Thumzup's growth trajectory remains strong, and the Company expects to reach 1,000 advertisers by mid-Q2 and 5,000 advertisers by the end of 2025.

TZUP

Thumzup Media Surpasses 900 Advertisers, CAGR Of 220%; Expects To Reach 1,000 Advertisers By Mid-Q2 And 5,000 Advertisers By 2025 End

Secure Energy Services (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SES#TSX">SES</a>) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.26 by 38.46 percent. This is a 89.12 percent decrease over earnings of $1.47 per share from the same period last year. The company reported quarterly sales of $371.00 million which beat the analyst consensus estimate of $351.00 million by 5.70 percent. This is a 3.06 percent increase over sales of $360.00 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

TSX:SES

Secure Energy Services Q1 EPS $0.16 Misses $0.26 Estimate, Sales $371.00M Beat $351.00M Estimate

Stifel analyst Frank Galanti upgrades FTAI Aviation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) from Hold to Buy and maintains the price target from $123 to $123.

Upgrades

FTAI

Stifel Upgrades FTAI Aviation to Buy, Maintains Price Target to $123

Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) shares are trading higher after the company&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45161321/exxonmobil-announces-first-quarter-2025-results" rel="noreferrer noopener">reported&nbsp;first-quarter&nbsp;results</a>.&nbsp;
Total revenues and other income&nbsp;stood at&nbsp;$83.1 billion, missing the consensus of&nbsp;$86.1 billion.
ExxonMobil's total output held steady at 4.55 million barrels of oil equivalent per day in Q1.
Also Read: <a target="_blank" href="https://www.benzinga.com/etfs/specialty-etfs/25/04/44949075/from-oil-rigs-to-runways-exxon-mobil-boeing-get-the-leveraged-trading-treatment" rel="noreferrer noopener">From Oil Rigs To Runways: Exxon Mobil, Boeing Get The Leveraged Trading Treatment</a>
Adjusted earnings dropped to $7.71 billion from $8.22 billion in Q4 2024, weighed down by weaker refining margins and lower crude prices.
Adjusted EPS stood at&nbsp;$1.76,&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">beating the consensus of&nbsp;$1.70</a>.
Operating cash flow from operating activities stood at $13.0 billion and free cash flow came in at $8.8 billion in the quarter.
Exxon's&nbsp;capital expenditures stood at&nbsp;$5.9 billion in the&nbsp;quarter, including $5.9 billion of additions to property, plant, and equipment.
The company achieved a cumulative structural cost savings of&nbsp;$12.7&nbsp;billion&nbsp;versus 2019, including savings of&nbsp;$0.6&nbsp;billion&nbsp;in the quarter.
The company expects to deliver cumulative savings of&nbsp;$18 billion&nbsp;through <a target="_blank" href="https://www.benzinga.com//node/43389620" rel="noreferrer noopener">the end of 2030 versus 2019</a>.
Dividend &amp; Repurchase: Exxon expects a&nbsp;second-quarter dividend per share of&nbsp;$0.99, payable on June 10, to shareholders of record as of&nbsp;May 15, 2025.
The company's shareholder distributions totaled&nbsp;$9.1&nbsp;billion&nbsp;in the quarter, comprising&nbsp;$4.3&nbsp;billion&nbsp;in dividends and&nbsp;$4.8&nbsp;billion in share repurchases.
As announced earlier, ExxonMobil plans to expand its annual&nbsp;$20 billion&nbsp;share repurchase program through 2026.
Darren Woods, chairman and chief executive officer, said, "This year, we're starting up 10 advantaged projects that are expected to generate more than $3 billion of earnings in 2026 at constant prices and margins.&nbsp;Continuously leveraging our competitive advantage is enabling the company to excel in the current market environment and deliver on our plans through 2030 and far into the future."
Investors can gain exposure to XOM via EA Series Trust Strive U.S. Energy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRLL#NYSE">DRLL</a>) and&nbsp;Fidelity MSCI Energy Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FENY#NYSE">FENY</a>).
Price Action: XOM shares are up&nbsp;1.22% at $107.07 premarket at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/buybacks/25/05/45164086/chevron-q1-profit-drops-on-higher-costs-weak-international-margins" target="_blank" rel="noreferrer noopener">Chevron Q1 Profit Drops On Higher Costs, Weak International Margins</a></li>
</ul>
Photo: Ken Wolter/Shutterstock

Equities

Large Cap

Guidance

Movers

DRLL

FENY

Exxon Mobil Q1: Steady Production, Focus On Cost Cuts And Stock Buyback

The U.S. labor market showed signs of strength in April, with hiring momentum topping estimates despite the impact of <a href="https://www.benzinga.com/topic/tariffs">trade tariffs across industries.</a>
Nonfarm payrolls increased by 177,000 last month, slightly down from a downwardly revised 185,000 in March, according to data released Friday by the Bureau of Labor Statistics. 
The outcome surpassed both economist forecasts for a 130,000 gain and betting markets – tracked by CFTC-regulated platform Kalshi – which had priced in a 90,000 increase.
In April, employment continued to rise across several sectors, including health care, transportation and warehousing, financial activities, and social assistance, while federal government jobs declined.
The health care sector added 51,000 jobs—closely in line with its 12-month average of 52,000. Notable increases were seen in hospitals, up 22,000, and ambulatory health care services, up 21,000.
Transportation and warehousing employment rose by 29,000, rebounding from a modest gain of 3,000 in March. Within the sector, job growth was concentrated in warehousing and storage, up 10,000, couriers and messengers, up 8,000, and air transportation, up 3,000. 
Federal government employment declined by 9,000, reflecting rising layoffs amid reforms led by Elon Musk's Department of Government Efficiency (DOGE).
The unemployment rate remained unchanged at 4.2%, as expected. 
Wage growth lost some momentum. Average hourly earnings rose 0.2% on the month, down from both the prior and expected 0.3%. On an annual basis, wages were up 3.8%, steady from March but slightly below the forecasted 3.9%.
Ahead of the April jobs report, money markets had priced in a 58% probability of a 25-basis-point rate cut at the Federal Reserve's June meeting, according to CME FedWatch.
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Indicator</th>
<th>April 2025</th>
<th>March 2025 </th>
<th>Forecast</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nonfarm Payrolls</td>
<td>177,000</td>
<td>185,000 (downwardly revised from )</td>
<td>130,000</td>
</tr>
<tr>
<td>Unemployment Rate</td>
<td>4.2%</td>
<td>4.2%</td>
<td>4.2%</td>
</tr>
<tr>
<td>Avg. Hourly Earnings (MoM)</td>
<td>+0.2%</td>
<td>+0.3%</td>
<td>+0.3%</td>
</tr>
<tr>
<td>Avg. Hourly Earnings (YoY)</td>
<td>+3.8%</td>
<td>+3.8%</td>
<td>+3.9%</td>
</tr>
</tbody>
</table>
</figure>
<h3 class="wp-block-heading">Market Reactions </h3>
The stronger-than-expected jobs data pushed the U.S. dollar and Treasury yields higher and boosted gains across major equity indices.
The U.S. Dollar Index, as tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), trimmed session losses, down 0.2% by 8:35 a.m. ET. 
Treasury yields also rose, with the 2-year yield—often seen as a proxy for near-term rate expectations—rising 3 basis points to 3.74%.
S&amp;P 500 futures were up 0.7%, while tech stocks rose 0.8%. On Thursday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) closed 0.7% higher, marking its eighth consecutive session of gains.
Read now: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45154011/gold-leaves-sp-500-in-the-dust-with-biggest-outperformance-in-14-years">Gold Leaves S&amp;P 500 In The Dust With Biggest Outperformance In 14 Years</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Econ #s

Economics

PowerShares DB US Dollar Index Bullish Fund

April Jobs Blow Past Expectations, But Tariff Storm May Be Brewing

The Board of Directors of&nbsp;MSA Safety Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSA#NYSE">MSA</a>) today approved the company's 55th consecutive annual dividend increase, raising the quarterly dividend from $0.51 per common share to $0.53 per common share. &nbsp;The change reflects a 4% increase in the quarterly dividend and a 5% increase in 2025 dividends per common share compared to 2024. The dividend is payable on June 10, 2025, to shareholders of record on May 15, 2025.
The Board of Directors also declared a dividend of $0.5625 per share on preferred stock, payable June 1, 2025, to shareholders of record on May 15, 2025.
 &nbsp;

Dividends

MSA Safety Hikes Quarterly Dividend By 4% From $0.51 To $0.53 Per Share

Aegis Brands (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AEG#TSX">AEG</a>) reported $4.16 million in sales this quarter. This is a 8.29 percent decrease over sales of $4.54 million the same period last year.

TSX:AEG

Aegis Brands Q1 Sales $4.16M Down From $4.54M YoY

In a strategic move to stimulate domestic consumption, China is reportedly turning to the K-pop industry amid its ongoing&nbsp;trade war with the United&nbsp;States and a weakening domestic market.
What Happened:  China is set to host K-pop group Epex for a concert in Fuzhou, Fujian province, on May 31. This event marks the first performance by an all-Korean idol group in mainland China since 2016. Additionally, South Korea&#8217;s longest-running K-pop event—the Annual Dream concert- is set to take place on September 26 in China&#8217;s Hainan province, <a href="https://www.cnbc.com/2025/05/02/china-looks-set-to-turn-to-k-pop-sector-as-us-tariffs-bite.html?ref=biztoc.com">reported </a>CNBC.
These developments suggest a possible relaxation of China&#8217;s unofficial ban on K-pop acts, a shift that CGS International Securities Hong Kong research analyst Oh Jiwoo refers to as a &#8220;structural turning point&#8221; for the industry.
In February, CGS stated China&#8217;s concert market, which expanded by 189% from $2.9 billion in 2019 to $8 billion in 2024, could see a significant boost in 2025 if the country lifts the unofficial ban on South Korean artists.
SEE ALSO:&nbsp;<a href="https://benzinga.com/25/05/45159157/mcdonalds-ceo-the-us-economy-is-dividedlow-income-traffic-down-10-while-rich-diners-continue-to-spend" target="_blank" rel="noreferrer noopener">McDonald&#8217;s CEO: &#8216;The US Economy Is Divided&#8217; As Wealthy Customers Keep Coming While Regular Families Cut Back</a>
Why It Matters:&nbsp;Recently, China&#8217;s Ministry of Culture and Tourism released a notice encouraging cultural events, such as concerts and music festivals, as per CNBC. The K-pop sector, unaffected by cross-border tariffs, is viewed as a strategic initiative to boost discretionary spending in tourism, hospitality, and local commerce.
According to analysts, China&#8217;s softened approach to K-pop also serves a diplomatic purpose, aiming to rebuild relationships with neighboring countries, such as South Korea, amid trade uncertainties. This shift may help revive K-pop&#8217;s fan-driven revenue streams in the region and promote regional goodwill.
Notably, President Donald Trump earlier this week indicated about &#8216;potential&#8217; trade deal with South Korea, besides India and Japan.
On Friday, China&#8217;s Commerce Ministry said that the country is <a href="https://www.benzinga.com/25/05/45160145/china-says-door-is-open-for-talks-while-it-is-assessing-us-trade-proposal-but-warns-coercion-and-extortion-wont-work">assessing </a>a U.S. offer to discuss the crippling 145% tariffs imposed by Trump. This move towards de-escalation comes amid China&#8217;s <a href="https://www.benzinga.com/news/global/25/04/45094345/as-chinas-manufacturing-contracts-beijing-releases-defiant-video-calling-us-a-paper-tiger-and-vows-to-never-kneel-to-trumps-trade-war">manufacturing activity</a> contracting for the first time in three months.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/25/04/45074825/jeff-bezos-says-an-employee-looked-at-me-like-i-was-the-stupidest-person-theyd-ever-seen-then-offered-a-simp" target="_blank" rel="noreferrer noopener">Jeff Bezos Says An Employee &#8216;Looked At Me Like I Was the Stupidest Person They&#8217;d Ever Seen&#8217; — Then Offered A Simple Idea That Changed Amazon</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Markets

China Turns To K-Pop For First Time Since 2016 To Spur Consumption, Strengthen Ties With South Korea Amid US Trade Tensions

Barrington Research analyst Alexander Paris maintains Perdoceo Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRDO#NASDAQ">PRDO</a>) with a Outperform and raises the price target from $35 to $38.

Comments

TC BioPharm (Holdings)

空売り

TC BioPharm (Holdings) (OTC:TCBPY) 株価情報, 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル